To investigate the impact of TAF1 mutations on medium spiny neuron (MSN) susceptibility, Tshilenge et al. conducted proteomic examinations on NSCs and induced pluripotent stem cell-derived MSNs obtained from human XDP patients. This evidence concerns the gene TAF1 and X-linked dystonia-parkinsonism.